Nature Reviews Drug Discovery 17, 641–669 (2018)
Details related to the copyright permissions for the images shown in Figure 3 have been added to the figure legend.
Additional information
The online version of the original article can be found at https://doi.org/10.1038/nrd.2018.110
Rights and permissions
About this article
Cite this article
Deverman, B., Ravina, B., Bankiewicz, K. et al. Erratum: Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov 17, 767 (2018). https://doi.org/10.1038/nrd.2018.158
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2018.158
This article is cited by
-
Prospects for gene replacement therapies in amyotrophic lateral sclerosis
Nature Reviews Neurology (2023)
-
Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson’s disease models in vitro and vivo
Molecular Medicine (2022)
-
miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases
Cellular and Molecular Neurobiology (2022)
-
Evolving therapies in neuronopathic LSDs: opportunities and challenges
Metabolic Brain Disease (2022)
-
Strategies for delivering therapeutics across the blood–brain barrier
Nature Reviews Drug Discovery (2021)
